CMPX

COMPASS THERAPEUTICS, INC.

CMPX · CIK 1738021 · Annual (10-K) · Last 6 years

Financial Trends

Revenue
20192024
Net Income−$49M
20192024
Operating CF−$45M
20192024
Free Cash Flow−$45M
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue——————
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.0B———$0.0B—
SG&A Expense——————
Operating Income$-0.1B$-0.1B$-0.0B$-0.1B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-0.36$-0.33$-0.37———
EPS (Diluted)——————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.1B$0.2B$0.2B$0.2B$0.1B$0.0B
Current Assets$0.1B$0.2B$0.2B$0.1B$0.1B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.2B$0.1B$0.0B$-0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.0B$-0.2B$-0.0B$0.0B—
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B—
Financing Cash Flow$0.0B$0.0B$0.1B$0.1B$0.0B$0.0B
← Companies